Clinical Trial Update: A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination [Phase 1]

View source ↗

Summary

Pfizer's Phase 1 study of PF-07329640, given alone or in combination, in advanced/metastatic solid tumors including non-small cell lung cancer, colorectal cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Melanoma
• Non-small Cell Lung Cancer
• Urothelial Cancer

Drugs mentioned

• PF-07329640

Snippet

Sponsor: Pfizer | Conditions: Advanced or Metastatic Solid Tumors, Non-Small Cell Lung Cancer | Phase 1 | Status: TERMINATED